ArriVent BioPharma, Inc. (AVBP) › Net IncomeArriVent BioPharma, Inc. (AVBP) — Net IncomeAnnual figures by fiscal year, from SEC filings.2023: -$69.33M2024: -$80.49M2025: -$166.31M-$166.31M2023Net Income (USD)2025Fiscal YearNet IncomeChange YoY2025-$166.31M-106.6%2024-$80.49M-16.1%2023-$69.33M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share